NCT01556776 2022-01-05A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line TherapyGerman CLL Study GroupPhase 3 Completed89 enrolled
NCT00774345 2021-12-02A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line TherapyCelgenePhase 3 Completed317 enrolled 13 charts